GlassScriptPhysician profile
Sasha Hernandez
NPI 1164146965
$1,482.60
in general payments reported to CMS, 2019-2025
13 companies · $517 in 2025
The $517 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $388 · 2024: $578 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $300.05 | 2023-2025 | Accolade Sr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.06 | 2023-2025 | Relistor |
| Nevro Corp. | $210.14 | 2024 | Senza |
| Medtronic, INC. | $190.00 | 2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $173.75 | 2023 | Proclaim |
| Biotronik Nro, INC. | $94.86 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $64.66 | 2025 | Evoke |
| Globus Medical, INC. | $45.58 | 2025 | Senza |
| Valinor Pharma, LLC | $38.92 | 2023 | Movantik |
| Bioventus LLC | $28.90 | 2025 | Durolane |
| Si-Bone, INC. | $25.30 | 2024 | |
| Averitas Pharma INC. | $22.17 | 2023 | Qutenza |
| Collegium Pharmaceutical, INC. | $20.21 | 2023 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sasha Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.